Dibact 250mg/31.25mg Injection
Marketer
Maneesh Pharmaceuticals Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Dibact 250mg/31.25mg Injection
Combiflox 250 mg/31.25 mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and spread. Administration must be solely under a doctor's guidance; adhere strictly to the prescribed schedule, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and digestive upset are potential side effects; consult your physician if these worsen. Seek immediate medical attention for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your doctor about all other medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor might order tests to monitor the medication's effects.
Uses of Dibact 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Dibact 250mg/31.25mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Dibact 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Dibact 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Dibact 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum 250 mg/31.25 mg Injection (Dibact) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial resistance, thus boosting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol ingestion alongside Dibact 250 mg/31.25 mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Dibact 250 mg/31.25 mg is typically regarded as safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
Administering Dibact 250 mg/31.25 mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Dibact 250 mg/31.25 mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Dibact 250 mg/31.25 mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Administering Dibact 250 mg/31.25 mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage changes for Dibact 250 mg/31.25 mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Dibact 250mg/31.25mg Injection :
Omit a dose of Dibact 250 mg/31.25 mg Injection? Seek your physician's advice.
Facts to Know About Dibact 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently